A University of Alberta spinoff company has received FDA approval for an artificial intelligence tool that could revolutionize thyroid ultrasounds, making the procedure faster and easier for thousands of Canadians who undergo it each year. MEDO.ai, with offices in Edmonton and Singapore, received approval last month from the U.S. Food and Drug Administration for its...
